Abcam is a global life science company enabling scientific breakthroughs by serving life scientists to achieve their mission, faster. We partner with global life science and clinical communities to deliver next-generation tools and solutions to help accelerate research and lead to new discoveries that positively impact society.

ACROBiosystems Group, founded in 2010 and listed in 2021, is a biotechnology company aimed at being a cornerstone of the global biopharmaceutical and health industries by providing products and business models innovation. The company spans across the globe and maintains offices, R&D centers, and production bases in 12 different cities within the United States, Switzerland, England, Germany, and China.

Actemis has been assisting Health start-ups (Biotech, Medtech) for several years in their search for funding for their Research, Development and Innovation activities and also on tax measures (CIR, CII, JEI). The Actemis Health Unit will support you in all your projects thanks to the implementation of specific monitoring tools for Health companies as well as regular monitoring of calls for projects in the Health sector.

Actome‘s Protein Interaction Coupling (PICO) technology supports life science research and development by enabling the quantification of proteins and protein interactions in biological samples with unprecedented ultra-high sensitivity and flexibility. The PICO technology combines the advantages of immunoassays and digital PCR by translating protein status into DNA barcodes. Our kits provide a simple and robust sample-to-result workflow.

The AFSSI, the French Association of Service and Innovation Companies for the Life Sciences has the desire to unite French companies of services and technological innovation in the strategic field of Life Sciences.
These innovative companies evolve in the pre-clinical phases, but also clinical, constitute the force of our sector; dynamic and highly qualified actors, constituting a diversified fabric of scientific providers essential to the development of industries in the Life Science.

Alsalogpharma offers you an innovative service for your research and development activities.
Our mission is to route your ultra-sensitive flows in accordance with your requirements, offering a guarantee of confidentiality, security, (real-time direct traceability) and processing speed.
Our tailored solutions will offer you all the required support to provide you with the quality and technological maturity and help you focus on your core business : fundamental research.

AND BioPharma BV uses patented technology to produce self inhibiting nucleotides that manage pathogen populations. Simply said: Any organism ingesting, up taking or even in touch with too much selfDNA will stop growing, wither and die. We focus on topical livestock conditions in the tropics and in Europe.

ANS Biotech is a preclinical CRO exclusively dedicated to the in vivo pharmacology of Pain/Well-being.
Our mission is to help our Clients to evaluate the efficacy of their candidates in our preclinical models of pain.
Since 2006, we have accompanied more than 150 clients around the globe to build step by step their preclinical dossier.
As an extension of your scientific team wherever you are located around the world, we help you to optimize and accelerate the development of your drug candidat.

Ardena is a fully integrated contract development & manufacturing organization (CDMO) with a core focus on bringing molecules to the clinics. The company provides pharmaceutical development services. The company offers services in the areas of analytical development, formulation and process development, stability study, drug product manufacturing, clinical supply, and regulatory and quality management support.

ARXUM is a European software company based in Germany and specialized in industrial automation for the Pharma market.

Since 2018, ARXUM has been a pioneer in cutting-edge technologies (blockchain & assisted reality) that are truly beneficial in biotech labs and pharmaceutical supply chain management.

Thanks to a team of tech experts and the supports of the European Commission and the Polepharma, ARXUM offers state-of-the-art solutions to improve the biotech processes and data integrity.

Asklesoft digitalizes your Qualifications & Validations from the URS to the PQ according to the requirements of the FDA 21 CFR Part 11 and the EMA Annex 11. Our cloud based solution is a powerful tool saving time, reducing your costs and giving you tools to drive your team more efficiently.
Ask us for a free demo and change the way you process your FAT, SAT, IQ, OQ, PQ.

Atlantic Bone Screen is a French CRO specialized in high-quality preclinical evaluation services.
We have a strong know-how in the field of bone and joint diseases and in oncology.
We provide in vitro tests, animal models and other technical services for imaging, histology and histopathology.
We support our Customer to identify and characterize the therapeutic potential of drug candidates, nutraceuticals and biomaterials through tailor-made preclinical studies.

Bachem is a leading, innovation-driven company specializing in the development and manufacture of peptides and oligonucleotides. The company, which has over 50 years of experience and expertise, provides products for research, clinical development and commercial application to pharmaceutical and biotechnology companies worldwide and offers a comprehensive range of services. Bachem operates internationally with headquarters in Switzerland and locations in Europe, the US and Asia. The company is listed on the SIX Swiss Exchange.

BIOCentre, Ltd. is biotech incubator and scientific research institution in Croatia. BIOCentre provide offices and laboratories, conduct training and consultancy start-ups established biotech companies, connects companies, universities and institutes. Central Laboratory’s specialized units Microbiology, Cell biology, Downstream processing, Proteomics and Bioanalytical chemistry are specialized to design the process optimization from biomass production up to a final biological product.

Based in Grand Est Region, the Cluster BioValley France brings to the health sector its unique expertise and personalized support program around 4 fields of expertise:

• drugs and innovative therapies: genetic and cellular therapies, bioproduction, clinical assessment tools…
• medical technologies: robotics and image guided surgery, implantable medical devices…
• e-health: simulation and decision support tools, patient follow-up…
• diagnosis: biomarker, imaging, fast diagnosis…

BiPER TX is a biotech start-up developing first-in-class drug candidates against cancers with high unmet medical needs. Our first drug candidate, BPR001 is at 15 months from the clinic and has been developed to treat gastro-intestinal cancers in oral administration. Our first portfolio of patented small molecules target specifically BIP a key controler of the ER Stress, a pro-survival and resistance pathway, leading to tumour growth inhibition in a broad range of cancer indications.

BIPP is a Belgian e-Procurement platform for public and private organizations active in Life Sciences, Healthcare, Biotech and Pharma. Designed for scientists, we have fully automated the procurement cycle for the sector. Our mission is to ensure more time and savings for science by bringing daily operational excellence in procurement with a focus on the end-user. BIPP has available variety of workflows, comprehensive database – 11K+ sector specific suppliers, contract and prevention compliancy.

CARBOGEN AMCIS leverages world-class chemistry skills to provide drug development and commercialization services to pharmaceutical and biopharmaceutical companies. Our cGMP-compliant infrastructure includes dedicated Highly Potent facilities and a clean room for Antibody Drug Conjugates. We also offer high-quality Cholesterol and Vitamin D analogs.
Learn more at www.carbogen-amcis.com

CER Groupe is a CRO supporting human and veterinary health by providing research services to companies active in the biotech, pharma, food and agrotech fields. Our activities focus on non-clinical development, biomanufacturing and food testing services, supported by strong analytical platforms and expertises. Our teams are committed to offer flexible and integrated solutions, from discovery to toxicity evaluation and routine services, at the highest quality standards (ISO9001, ISO17025 and GLP).

CILcare is the world’s leading R&D services company specialized in ear disorders. Based in Montpellier, Boston, Paris, and Copenhagen, CILcare supports pharma, medtech, animal health and nutraceutical industries to assess efficacy and safety of drugs, cell & gene therapies, and medical devices, on hearing loss, tinnitus, otitis, and ototoxicity. CILcare’s mission is to make hearing a priority & give hope to the 1.5 billion people worldwide waiting for effective solutions.

Bio-engineered Exosomes to tackle diabetes, inflammation, infectious diseases and more.
Ciloa is the most experienced exosome-based R&D power house dedicated to the development of preventive and therapeutic innovative solutions using a patented technology to bio-engineer exosomes. Its technology provides solutions to the major challenges in the development of exosome-based bio-therapeutics which are: targeting specificity, cargo loading, stability, and production of large amounts of pure exosome.

Cynbiose is a non-clinical CRO specialized in non-human primate (NHP) models for biomedical research.
We perform preclinical services ranging from exploratory DMPK, early safety and immunogenicity studies for NCEs, immunotherapies, gene therapies and vaccines.
We also propose PoC studies in several therapeutic areas such as infectious and respiratory (BSL-2 to 3), CNS, immunology, …
Our France-based facility is AAALAC accredited and studies performed in a GLP-like environment.

Deeptope offers a deeptech methodology for therapeutic protein development. It combines high throughput in vitro mutagenesis, Yeast Display, FACS and NGS to characterize protein interactions and perform multiparametric lead optimization.

Domain Therapeutics is a clinical-stage biotech delivering immunotherapies targeting GPCR-mediated immunosuppression. Our high-value proprietary programs consist of first-in-class and best-in-class strategically positioned assets regarding tumor subtypes and patient subpopulations for optimal outcome.

DRUGABILIS is an established CRO specialized in pharmaceutical drugability of R&D compounds, including cytotoxic drugs. Our expertise includes API Solid Form Optimization (salts, polymorphs, cocristals) & Early Formulation, ranging from animal formulation (efficacy, PK, Tox) to early clinical formulation feasibility assessment (oral low soluble, injectable, ocular, dermal, vaginal …). Our new facilities and recent hirings and new equipments allow us increasing our capacities for new projects.

We offer training programmes related to clinical research, quality assurance, regulatory affairs, as well as soft skills needed to excel in your job. All our programmes are globally recognised and offer participants a learning journey, with the support of ad hoc training material and a comprehension assessment and certificate. Our courses are carried out in classroom, live webinars and eLearning, or a blend thereof.

ENTEROSYS is specialized in the preclinical evaluation of compounds of interest on the digestive sphere, the enteric nervous system and the communication between the gut and peripheral organs. Thanks to innovative state-of-the-art techniques based on the analysis of physiological parameters in real time, our expertise allows us to develop proofs of concept and to study precisely the mechanisms of action of molecules of therapeutic interest (i.e. drug candidates, dietary supplements, …).

The core mission of EFS is to ensure national self-sufficiency in labile blood products. EFS also carries out research activities in cutting-edge fields related to cell therapy, biotechnology, diagnostic and transfusion. The EFS also has bioproduction facilities.

Eurofins CDMO provides integrated, end-to-end development and manufacturing services for Drug Substance/API and Drug Product of small molecules and biologics. Our services: Formulation Development, Non-GMP & GMP Manufacturing (Sterile & Non-sterile), Clinical Packaging and Logistics including for highly potent compounds, poorly soluble drugs, lyophilisation processes and specific therapeutic areas (immunotherapies, orphan drugs, pediatric dosage forms, etc.)

Eurofins Genomics is part of the Eurofins Group and an internationally leading provider of Sanger DNA sequencing services, NGS services, genotyping services, DNA & RNA synthesis and bioinformatics services for pharma, diagnostics, food, agriculture, biotechnological and research markets. The company’s strength is its extensive customer base and high-quality services in industrial scale for the life science industries and academic research institutions around the world.

EVOLY Consulting is an innovation funding management consulting company created in 2012.
Based in Lyon, we combine the expertise of our multidisciplinary team to offer strategic and operational consulting services across Europe.
Whether you are a start-up, an SME or a multinational, we use our expertise to identify and activate the funding mechanisms appropriate to your R&D and innovation projects.

FastCompChem aims at improving drug discovery through accurate quantum chemical methods. With very high rates of attrition due to safety concerns, having early accurate predictions of possible toxic effects will dramatically improve the process of drug discovery. Ultimately, only compounds with good safety profiles should proceed to clinical trials. FastCompChem is developing quantum computational toxicology tools for early stage drug discovery.

FINDMED is a consortium of 18 French leading research institutions involved in healthcare at large and that have got the “Carnot” label for their ability to conduct R&D partnerships with companies . FINDMED’s mission is to help French companies, in particular start-up and SMEs, to access the expertise and the technological platforms of its members. FINDMED is therefore companies’ R&D partner for their innovation projects, whether they be biotech and/or medtech.

Firalis is a french biotech company based in France, at the border with Switzerland and Germany. The company was created 15 years ago and specialized into biomarker discovery and personnalized medicine services.
We support international drug research and development with academia, biotechs and pharmaceutical labs by providing sample analysis services in Neurology, Oncology and Immunology. Thanks to our cutting-edge analytical tools and expert team, we bring a complete multi-omics approach.

Fleming Associés, Insurance Partner Facilitator of Businesses impacting Health and Healing.
We are specialise in insurance for clinical trial, public liability of biotech companies, cyber risk, P&C insurance (laboratory, offices…). We make true commitments in termes of quick response and sending times (responsiveness), follow-up points for clients care, defense in case of disaster.

France Biotech is an independent association that brings together the country’s leading innovative health companies. As a leader in health innovation and a privileged intermediary with public authorities in France and Europe, France Biotech’s mission is to support the development of this industry in France, by improving the tax, legal, regulatory and managerial environment in which these companies operate and by advocating for their recognition as a leading-edge industry.

Located in the heart of Europe, Grand Est is a very attractive territory and a leading player in the health industry. Our regional innovation strategy (S3 2021-27) has clearly highlighted the high growth potential of health market in three sectors : medical devices, biotechnology and digital health tools. Our ambition is now to accelerate economic transitions and create a unique environment to attract new players and promote excellence in research and innovation initiatives.

HC NEXT is specialized in project management and vendor management for drug development.
We support pharma and biotech to
– Structure the project, with all its components, to secure and accelerate the passage of key milestones
– Optimize the generation and organization of valid and relevant data
– Select & coordinate the vendors (Clinical, CMC, Regulatory, Quality Assurance…)
– Catch up on a drifting project
Eurasanté preferred partner, we also support incubated companies in early stages

Ilonov is a preclinical stage biotech developing first-in-class biologics against chronic metabolic diseases, harvesting the potential of muscle secretome to regulate metabolism, a novel & unexplored approach. Our biotherapy specifically preserves & stimulates pancreatic beta cell function by restoring the integrity of the extracellular matrix of the islet niche. Discovered in human muscle post-exercise, our asset has already proven safety & efficacy in preclinical T1D & T2D models in vivo.

As an innovative and dynamic contract research organization (CRO) InnoSer supports the preclinical pipeline from its facilities in Belgium and the Netherlands. Founded in 2012, our in-depth expertise allows us to provide customized and streamlined early drug development options with well-characterized and near-patient research models.

Lifespin is building a smart health diagnostic platform that combines biology and data science to enable digital metabolic insights for precision diagnostics, personalized disease management, and precision drug monitoring. Lifespin products are software algorithms scalable as SaaS. Our constantly growing database of digital metabolic profiles, with currently more than 180.000 individuals, enables the analysis of more than one billion metabolic relationships.

RD-BIOTECH & SYnAbs are part of MABEXPERTS, an European alliance of synergetic companies combining high expertise, technical skills and scientific know-how in Antibody Engineering: From DNA to Biotherapeutics.
SYNABS: Proprietary technologies and rat-LOU species, mAb development, high success rate in generating Ab against difficult targets
RD-BIOTECH: Custom development and biomanufacturing of pDNA, mAb, recombinant protein and antibody (Fab, scFv…). From pilote to large scale.

Our mission is to be the premier source of animal models and related services for the preclinical research and development of human medicines, vaccines, medical devices, and other therapies, as well as for the clinical research and development of companion animal pharmaceuticals.

For over 80 years our animals have contributed to the development of life saving therapies and treatments for humans and animals alike. We hold ourselves to the highest standards of health and quality, and AAALAC acc

MediTox is a GLP-certified CRO having experience in variety of compounds and therapeutic areas, with an experts and associates teams capable to conduct a number of experiments in full compliance with GLP standards and with another international guidelines (EMA/ICH, VICH, OECD, US FDA, ISO10993), providing core range of nonclinical studies supporting phases I – III of clinical trials and/or registration of human & veterinary drugs, medical device, food/feed additives.

Microsynth (founded in 1989) is a leading European company in nucleic acid synthesis & analysis. The main activities are divided into following three business areas:

1. DNA/RNA Synthesis
2. DNA/RNA Analysis and Sequencing
3. Contract Research/Outsourcing

As a leading European CDMO, Minakem offers services for the process development, scale-up, commercial cGMP production and full life cycle management of small molecules APIs & HPAPIs.
Our process optimization and technical transfer approach is driven by Operational Excellence, with a focus on quality every step of the way.
In successful long-term partnerships, we support pharmaceutical and biotechnological companies in the development and manufacture of innovative treatments.

MyData-TRUST is the leading company specialized in Data Protection & Privacy, exclusively dedicated to the Life Sciences Industry. Our objective is to help organizations to comply with worldwide data protection regulations including EU/UK GDPR, US HIPAA, Swiss FADP, Chinese PIPL and Brazilian LGPD. Our services cover: training & eduction, risk assessments, legal support, externalized Data Protection Officer and Data Protection Representative.

Nextmed ; Strasbourg Healthcare district in the heart of Europe

Located in the heart of Strasbourg, nextmed brings together on more than 30 hectares all the doctors, researchers, entrepreneurs and patients to build the health of the future and imagine innovative solutions for patient care, particularly through digital technology and AI.
Since 2009, nextmed has created more than 1,000 jobs in the fields of e-health, medical technologies and robotics. It is aiming for 1500 additional jobs by 2030 with 25,000m² of office space dedicated to medical innovation.

Drug discovery CRO from gene to optimized lead. With more than 200 researchers, screening, fragments, covalent fragments and DEL. Biophysics: mass spectrometry, SPR, NMR, MST, DSF, HDX. Structural Biology: protein X-ray crystallography and cryo-EM — including membrane proteins. Chemistry: custom synthesis, process research, medicinal chemistry. Award winning medicinal chemists for integrated projects.

Oxeltis is a medchem services company with hit to lead optimization services in various therapeutic fields. Oxeltis’ scientific team has a recognized expertise in specific areas of organic synthesis: heterocycles, macrocycles, nucleosides/nucleotides, phosphoramidites, modified sugars, oligo/polysaccharides, and PROTAC. Oxeltis has completed over 35 projects and several drug candidates delivered to its customers are in clinical development. Oxeltis works in EU, Japan, and North America.

Company activities & offerings are categorized in 3 major areas:
1. Contract development & microbial biologics manufacturing (CDMO).
2. Development of Recombinant expression systems and process technologies for biologics and biosimilars.
3. Paras Biopharmaceuticals has developed and is offering Recombinant Bioprocess enzymes.

Pfizer CentreOne® is a global CDMO within Pfizer and a leading supplier of specialty APIs. Our global manufacturing network includes more than 35 sites across six continents. Backed by Pfizer resources, we deliver technical expertise, global regulatory support and long-term supply.

Working together with our customers, we combine our knowledge with open dialogue to solve challenges. For more information, visit www.pfizercentreone.com.

PharmaLex is the leading provider of specialized services for the pharma, biotech and medtech industries. We guide you from early strategic planning activities and non-clinical requirements through clinical development, regulatory submission processes and post-approval / maintenance post-launch activities. Our experts use technology-enabled solutions to support you through the entire product lifecycle delivering tailor-made solutions worldwide.

Poly-Dtech: A company specialized in the R&D of fluorescent nanomolecules in the field of healthcare and life sciences.

Our patented cutting-edge technology consists of ultra-fluorescent nanoparticles with unique features, offering an unrivaled performance that exceeds the current technical limits and allows the detection of various biomarkers far beyond what is possible nowadays, with user-friendly protocols and applicable to various molecular and cellular biology techniques.

PolyPeptide is a focused Contract Development & Manufacturing Organization (CDMO) for peptide- and
oligonucleotide-based active pharmaceutical ingredients. By supporting its customers mainly in pharma and biotech,
it contributes to the health of millions of patients across the world. PolyPeptide offers products and services from
pre-clinical through to commercial stages, including generics.

ProteoGenix is a leading life sciences organization which has been providing services in molecular biology, protein engineering and immunology since 2003. ProteoGenix is a French CRO with more than 19 years of experience in the following areas:
– Antibody engineering (Humanization, Bi-specific, ADC, stable cell line development)
– Monoclonal and polyclonal antibody development (Phage display, single B cell sorting, hybridoma)
– Recombinant protein/antibody production (5 different systems)

The SATT Network brings together 13 Technology Transfer Acceleration Companies in France. Committed to economic dynamism thanks to the scientific innovations resulting from public research, SATTs provide companies with high-potential technological solutions to improve their competitiveness.

With more than 650 startups created, the SATTs are the leading local players in the French government’s DeepTech Plan, operated by Bpifrance. They are connected on a daily basis to more than 150,000 researchers and offer privileged access to innovations from public laboratories. With their national network, they are the strategic partners of companies seeking growth through innovation.

RONDOL aims to adapt extrusion to the micro scale and to pharmaceutical standards, contributing to more efficient medicines and medical devices, with less side effects and toxicity, greener and cheaper . RONDOL was nominated at the Galien Awards, signed a global technology partnership with SEQENS and a research agreement against child malaria with BASF and QUB. Rondol provides horizontal and vertical extruders that meet the criteria of regulatory agencies.

Roowin is a privately owned Contract Research Organisation (CRO) headquartered at Riom, Auvergne, France. Its core business being in high value added fine chemistry, Roowin offers services in the following areas:
• GMP synthesis
• Process development
• Analytical methods
• and more
We are proud to be able to accompany our customers from early drug discovery over process development to medium-scale GMP production, supporting our operations by strong analytical chemistry capibilities.

Sartorius Stedim Biotech is a leading partner of the biopharma industry. Our solutions are supporting our customers to produce drugs safely, timely and economically. The key product categories of our company are cell cultivation, fermentation, filtration, purification, and fluid management.

Scinopsis is an experienced medical writing consultancy providing high-quality documents for the pharmaceutical, biotechnology and medical device industries.
We offer a comprehensive medical writing service to cover your regulatory/clinical and medical communications needs, from early clinical development up to registration and post-approval, across all therapeutic areas.
Scinopsis is well known for its flexible and friendly attitude and we will always endeavour to find the right solution.

Selvita is a preclinical CRO providing multidisciplinary support in resolving challenges of research within the area of drug discovery and drug development. Selvita was established in 2007 and currently employs over 1000 professionals, of which over 40% hold a PhD degree. The Company research sites are located in Krakow (HQ) and Poznan, Poland, as well as Zagreb, Croatia. The company offers drug discovery support at every stage of the early discovery phase up to the preclinical development.

Servier is a global independent pharmaceutical group governed by a Foundation. With a strong international presence in 150 countries and a total revenue of 4.7 B€ in 2021, Servier employs 21,800 people worldwide. To accelerate therapeutic innovation for the benefit of patients, the Group is committed to open and collaborative innovation with academic partners, pharmaceutical groups, and biotech companies. Servier growth is based on a sustained commitment to cardiovascular and metabolic diseases, oncology, neurosciences and immuno-inflammatory diseases. More information: servier.com

The French association for animal health industry (SIMV) represents manufacturers and marketers (on the French market) of medicines and reagents for pets and for farm animals. In order to contribute to the competitiveness of its member companies, the SIMV defines its value creation through its trades:

Federating ;
Anticipating;
Advising/training/informing;
Being watchful;
Representing the positions of its members.

SPARTHA Medical develops multifunctional coatings for medical devices and for daily use. Our patented coatings have antiviral, antimicrobial, and anti-inflammatory effects while avoiding bacterial resistance. We develop customized, implant-specific coatings that reduce implant-related complications. The coatings are intended for almost all complex surfaces of a wide range of medical devices (implants, dressings, surgical materials, …) as well as non-medical materials.

StemInov is a clinical stage spin-off from CHRU of Nancy and University of Lorraine that develops an off-the-shelf and allogenic cell therapy treatment in the field of inflammatory pathologies with a focus on critical care. More than a new product, our proprietary Stem cells from the Wharton jelly of umbilical cord, called WhartSep, is a new concept of immunomodulation and adaptive medicine firstly indicated and patented for the treatment of septic shock and Acute Respiratory Syndrome Disease.

Sterling Pharma Solutions is a global contract development and manufacturing organisation (CDMO) with more than 50 years’ experience in providing small molecule API development and manufacturing services, specialising in handling challenging chemistries.

Sterling manages the most complex API and API intermediate challenges from proof-of-concept to commercial manufacture, as well as Antibody Drug Conjugate (ADC) development and manufacturing services.

It has four sites; employing 900+ people.

SYNERLAB is a european leader in contract & development manufacturing, which mission is to support pharmaceutical firms in developing, manufacturing & packaging their products.
Our plants are designed to be flexible and enable the development of pharmaceuticals from laboratory scale to industrial scale, including clinical manufacturing. Development programs for new chemical entities represent more than 80% of our activity.

Syngene is an integrated CRO/CDMO serving the global pharmaceutical, biotechnology, nutrition, animal health, consumer goods and specialty chemical sectors. We offer end-to-end development and manufacturing services to advance clinical candidates from preclinical to NDA filing with ease. Our high-end capabilities for small molecules and biologics extend across drug substance, drug product, analytical development, ICH stability studies, commercial manufacturing, and clinical development.

Founded in late 2017, Temisis is a biotechnology company focused on the discovery and development of novel small molecule compounds to treat inflammatory diseases with high unmet needs. TEM1657, our lead program has showed great efficacy in pre-clinical studies, both orally and topically, to relieve psoriasis symptoms without the side effects associated with existing treatments. TEM1657 unique efficacy and safety profile is explained by its first-in-class MoA, currently under investigation.

Founded in 1887, as a one of the first university hospital worthy of the name, to soon become one of the largest medical facilitiy not only in Eastern Bohemia, but also throughout the Czechia. The most complex surgical procedures are performed and modern diagnostic and treatment technologies are used. This makes our hospital comparable to similar hospitals in Europe. In research, the UH HK aims to get the position of a research facility capable of participation in European research activities.

VIBIOSPHEN is a company specialized in infectious diseases. We lead the fight against virus – bacteria and fungi through innovative tools. Vibiosphen offers R&D services to support each step of the target product profile (TPP) definition: from identifying the right indication and defining the in vitro efficacy of the product to proving the in vivo safety and efficacy data of the molecule and determining the dose or route of administration.

— In vitro – organoids – 3D Tissues – In vivo —

WAINVAM-E is a young company developing quantum sensors  based on  the special optic and quantic properties of diamonds with Nitrogen Vacancy centers.

Our instruments are highly sensitive, accurate and stable. They represent a new generation of diagnostic and control tools, with a wide range of applications in many fields, from non-destructive testing for the energy, aeronautics fields, to the detection and diagnostic testing for the pharmaceutical and medical fields.

X’PROCHEM is a biotech company specialized in chemical synthesis of proteins for therapeutic and diagnostic use.
We are able to design and produce complex and highly customized proteins thanks to our robotic technology.
We can help you to produce proteins that are:
– Difficult to produce or to purify
– Need unnatural amino acids
– More efficient and reliable
– Proteins composed of up to 400 amino acids
– Contain a precise modification in the protein sequence
Our proteins are guaranteed

Xpress Biologics is a dynamic and customer-oriented Contract Development and Manufacturing Organization (CDMO) specialized in the development of manufacturing processes based on microbial expression systems (E. coli and P. pastoris) and the production of Biologics (recombinant proteins, antibody fragments and plasmid DNA) for the therapeutic, vaccine and diagnostic markets.

YesMyPatent is the digital service of IP firm Touroude & Associates, aiming at democratizing patent filing.

Innovation protection shall be accessible to all, in terms of costs, expertise quality and access to resources. We provide patent services worldwide through trusted foreign associates in each country.

At YesMyPatent by T&A, we give guidance to individual inventors, startup, large entities or public research groups who request a cost-efficient management of their IP.

As the world’s leading animal health company, we are driven by a singular purpose: to nurture our world and humankind by advancing care for animals. After 70 years innovating ways to predict, prevent, detect, and treat animal illness, we continue to stand by those raising and caring for animals worldwide – from livestock farmers to veterinarians and pet owners. A Fortune 500 company, we generated revenue of $7.8 billion in 2021 with ~12,100 employees. For more, visit www.zoetis.com.

Zymo Research is a globally established biotechnology company and industry leader in the fields of epigenetics, microbiomics and the emerging Next-Gen Sequencing space. With international facilities and a global distribution network, Zymo Research enables researchers in academia and the biomedical field to make cutting-edge discoveries all over the world and provides some of the most technologically advanced products in the industry.